David W. Cescon
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
- Cancer Research top 1%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
Papers in
- Oncology 96
- Cancer Immunotherapy and Biomarkers 32
- Cancer Treatment and Pharmacology 22
- HER2/EGFR in Cancer Research 17
- Cancer Cells and Metastasis 15
-
- Advanced Breast Cancer Therapies 44
- Co-authors
- Scott V. Bratman (5 shared papers)Lillian L. Siu (14 shared papers)Steven M. Chan (1 shared paper)Peter Schmid (17 shared papers)Tak W. Mak (18 shared papers)Vassiliki Karantza (20 shared papers)Sherene Loi (18 shared papers)Hope S. Rugo (19 shared papers)
- Journals
- Journal of Clinical Oncology (32 papers)Cancer Research (28 papers)Annals of Oncology (19 papers)Proceedings of the National Academy of Sciences (6 papers)Breast Cancer Research and Treatment (5 papers)
- Partner nations
- CanadaUnited StatesSpain
In The Last Decade
David W. Cescon
162 papers receiving 5.8k citations
David W. Cescon's Hit Papers
Peers
Comparison fields: 5 of 136
- Oncology 2.5k
- Cancer Research 1.2k
- Immunology 912
- Pulmonary and Respiratory Medicine 899
- Molecular Biology 1.6k
Countries citing papers authored by David W. Cescon
This map shows the geographic impact of David W. Cescon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. Cescon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. Cescon more than expected).
Fields of papers citing papers by David W. Cescon
This network shows the impact of papers produced by David W. Cescon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. Cescon. The network helps show where David W. Cescon may publish in the future.
Co-authors
The 25 scholars most cited alongside David W. Cescon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 171 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer Hit paper breakdown → | 2022 | 654 |
| 2 | Functional variants of OCTN cation transporter genes are associated with Crohn disease Hit paper breakdown → | 2004 | 596 |
| 3 | Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study Hit paper breakdown → | 2018 | 482 |
| 4 | Circulating tumor DNA and liquid biopsy in oncology Hit paper breakdown → | 2020 | 396 |
| 5 | 2019 | 161 | |
| 6 | 2019 | 144 | |
| 7 | 2014 | 142 | |
| 8 | 2020 | 138 | |
| 9 | 2017 | 138 | |
| 10 | 2017 | 124 | |
| 11 | 2008 | 119 | |
| 12 | 2015 | 105 | |
| 13 | 2005 | 102 | |
| 14 | 2014 | 101 | |
| 15 | 2022 | 100 | |
| 16 | 2021 | 94 | |
| 17 | 2017 | 90 | |
| 18 | 2018 | 90 | |
| 19 | 2023 | 76 | |
| 20 | 2019 | 73 |
About David W. Cescon
David W. Cescon is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Cell Biology, having authored 171 papers that have together received 5.9k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (44 papers), Cancer Genomics and Diagnostics (35 papers), Cancer Immunotherapy and Biomarkers (32 papers), Cancer Treatment and Pharmacology (22 papers), Breast Cancer Treatment Studies (21 papers), HER2/EGFR in Cancer Research (17 papers), Microtubule and mitosis dynamics (16 papers) and Cancer Cells and Metastasis (15 papers). The work is most often cited by research in Oncology (2.5k citations), Cancer Research (1.2k citations), Immunology (912 citations), Pulmonary and Respiratory Medicine (899 citations) and Molecular Biology (1.6k citations). David W. Cescon has collaborated with scholars based in Canada, United States and Spain. Frequent co-authors include Scott V. Bratman, Lillian L. Siu, Steven M. Chan, Peter Schmid, Tak W. Mak, Vassiliki Karantza, Sherene Loi, Hope S. Rugo, Hiroji Iwata and Benjamin Haibe‐Kains. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, Proceedings of the National Academy of Sciences and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.